Literature DB >> 35883910

Metabolic, Endocrine, and Cardiovascular Risks in Children with Overnutrition and Undernutrition.

Valeria Calcaterra1,2, Gianvincenzo Zuccotti2,3.   

Abstract

Malnutrition is a severe public health issue for both children and adults [...].

Entities:  

Year:  2022        PMID: 35883910      PMCID: PMC9317451          DOI: 10.3390/children9070926

Source DB:  PubMed          Journal:  Children (Basel)        ISSN: 2227-9067


Malnutrition is a severe public health issue for both children and adults [1]. It refers to deficiencies or excesses in nutrient intake, an essential nutrient imbalance, or impaired nutrient utilization [2]. The double malnutrition burden consists of both undernutrition (wasting, stunting, underweight, and mineral- and vitamin-related malnutrition) and overnutrition (being overweight, obesity, and diet-related noncommunicable diseases) [2]. Regarding children under 5 years of age, the World Health Organization (WHO) reported that 155 million are stunted, 52 million are wasted, 17 million are severely wasted, and 41 million present overweight and/or obesity [1]. Child growth is internationally recognized as a crucial indicator of nutritional status and health in various populations. There is a growing body of evidence suggesting that nutritional status can both positively and negatively modulate the organ systems involved in body homeostasis and development, thereby influencing the health risk [3]. Thus, malnourished children represent a “fragile” population and have an increased vulnerability as individuals to adverse health outcomes, including metabolic derangement, compared to others of the same age [4]. A synergistic effect of nutrition and metabolism on human health has been described. In fact, nutrition represents the process of nutrient acquisition from the environment, and metabolism is the process of transforming nutrients into substrates [5]. Both undernutrition and overnutrition can alter homeostatic interactions between nutrition and metabolism, leading to metabolic dysregulation. In the context of metabolic homeostasis, body composition data may provide further information on metabolic capacity and load; for example, muscle mass in relation to fat mass, visceral obesity, ectopic fat accumulation (e.g., in the liver, pancreas, and kidney), and muscle mass loss are much more strongly predictive of metabolic and endocrine disorders. The adipose tissue (AT) is considered an endocrine organ and can produce and release biologically active compounds involved in obesity-associated chronic inflammation and pathological metabolic processes [6]. In fact, in the presence of a positive energy balance, the AT undergoes morphological and metabolic changes leading to a massive release of pro-inflammatory cytokine-generating signals that recall the immune cells in place and that consequently result in an increase in the inflammatory infiltrates in the AT, hence the onset of chronic low-grade inflammation [7]. The initiating events of inflammation start early in childhood and modulate interconnected biochemical molecular pathways, such as stress adaptation, epigenetics, inflammation, macromolecular damage, metabolism, proteostasis, and stem cell and tissue regeneration, leading to comorbidities including diabetes, cardiovascular diseases, obesity, hypertension, hyperlipidemia, reduced reproductive capacity, and various cancers and related morbidity and mortality risks [7]. However, the skeletal muscle system is the largest organ in the human body, and not only is it important for mobility and strength, but it also acts as a regulator of metabolic processes and stores macronutrients [8]. In fact, the skeletal muscle secretes a variety of biologically and metabolically active polypeptide factors (myokines), providing coordination between whole-body physiology and energy balance. In patients with chronic diseases, factors such as immobility, malnourishment, hormonal alterations, poor blood flow to the muscle, endothelial dysfunction, and therapy can compromise muscular homeostasis [9]. Consequently, proteolytic processes and systemic inflammation can cause relevant skeletal muscle depletion, leading to dysmetabolism. Long-lasting adverse malnutrition effects in early life can also be attributed to interconnected biological pathways involving an imbalance in the gut microbiome. As reported by Iddrisu [9], the gut microbiota of children is influenced by diet, which, in turn, can impact a child’s nutritional status. The difference in the gut microbiome between lean and obese subjects has been well described. There might be particular gastrointestinal microbiomes that impart resilience to or present a risk of both undernutrition and overnutrition; the manipulation of the gut microbiota may alleviate the complications related to malnutrition [10]. Thus, it is important to consider that different conditions of pediatric malnutrition, including childhood obesity, prenatal malnutrition, and undernutrition and overnutrition in children with disabilities and/or other chronic diseases, such as inflammatory bowel diseases, chronic respiratory disorders, and cancers, are characterized by an altered body composition and a high metabolic load on a depleted capacity for homoeostasis [2], and they may be strongly associated with a functional decline across multiple inter-related systems, as well as with resistance to stressors, which can cause vulnerability [4,11,12] to the risk of cardiovascular disease, diabetes, metabolic syndrome, endocrine disorders, immune dysfunction, and chronic inflammation. Undernutrition and overnutrition have been usually approached as separate public health issues; however, the new emergent reality is that the two forms of malnutrition are interconnected. Therefore, double-duty actions that simultaneously address more than one dimension must be supported for effective policy solutions [2]. The early detection of comorbid conditions related to undernutrition and overnutrition is useful for developing personalized interventions and preserving health into adulthood. An appropriate nutritional status that can maintain metabolic homeostasis and regular physical activity to protect skeletal muscle mass are key elements for health and well-being, and for reducing endocrine, metabolic, and cardiovascular disease risks, particularly at the pediatric age.
  11 in total

1.  Frailty: enhancing the known knowns.

Authors:  Ruth E Hubbard; Olga Theou
Journal:  Age Ageing       Date:  2012-07-10       Impact factor: 10.668

Review 2.  The initiation of metabolic inflammation in childhood obesity.

Authors:  Kanakadurga Singer; Carey N Lumeng
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 3.  Risk factors and protective factors associated with incident or increase of frailty among community-dwelling older adults: A systematic review of longitudinal studies.

Authors:  Zeyun Feng; Marjolein Lugtenberg; Carmen Franse; Xinye Fang; Shanlian Hu; Chunlin Jin; Hein Raat
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

Review 4.  Importance of Nutrients and Nutrient Metabolism on Human Health.

Authors:  Yiheng Chen; Marek Michalak; Luis B Agellon
Journal:  Yale J Biol Med       Date:  2018-06-28

Review 5.  Nutritional Impact on Metabolic Homeostasis and Brain Health.

Authors:  Lionel Carneiro; Luc Pellerin
Journal:  Front Neurosci       Date:  2022-01-27       Impact factor: 4.677

6.  Metabolically Unhealthy Phenotype: A Key Factor in Determining "Pediatric" Frailty.

Authors:  Valeria Calcaterra; Hellas Cena; Annamaria Ruggieri; Gianvincenzo Zuccotti; Annalisa De Silvestri; Gianni Bonalumi; Gloria Pelizzo
Journal:  Pediatr Rep       Date:  2021-07-01

7.  Biochemistry of adipose tissue: an endocrine organ.

Authors:  Marisa Coelho; Teresa Oliveira; Ruben Fernandes
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

Review 8.  Skeletal muscle performance and ageing.

Authors:  Michael Tieland; Inez Trouwborst; Brian C Clark
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-11-19       Impact factor: 12.910

Review 9.  Sarcopenia and Heart Failure.

Authors:  Francesco Curcio; Gianluca Testa; Ilaria Liguori; Martina Papillo; Veronica Flocco; Veronica Panicara; Gianluigi Galizia; David Della-Morte; Gaetano Gargiulo; Francesco Cacciatore; Domenico Bonaduce; Francesco Landi; Pasquale Abete
Journal:  Nutrients       Date:  2020-01-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.